SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-022945
Filing Date
2023-06-29
Accepted
2023-06-29 16:54:24
Documents
16
Period of Report
2023-06-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 49667
2 ex4-1.htm EX-4.1 88194
3 ex4-2.htm EX-4.2 112179
4 ex10-1.htm EX-10.1 288933
5 ex10-2.htm EX-10.2 158727
  Complete submission text file 0001493152-23-022945.txt   1015060

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE atrx-20230629.xsd EX-101.SCH 3292
7 XBRL LABEL FILE atrx-20230629_lab.xml EX-101.LAB 34240
8 XBRL PRESENTATION FILE atrx-20230629_pre.xml EX-101.PRE 22365
10 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 2934
Mailing Address P.O. BOX 2161 WAKE FOREST NC 27588
Business Address P.O. BOX 2161 WAKE FOREST NC 27588 919-578-5901
Adhera Therapeutics, Inc. (Filer) CIK: 0000737207 (see all company filings)

IRS No.: 112658569 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-13789 | Film No.: 231058175
SIC: 2834 Pharmaceutical Preparations